EFFECTS OF PROSTAGLANDIN-E1, PROSTAGLANDIN-E2, PROSTAGLANDIN-F2-ALPHA, AND PROSTAGLANDIN-I2 ON ADRENERGIC TRANSMISSION IN GUINEA-PIG PULMONARY-ARTERIES

被引:6
作者
YASUDA, G [1 ]
MISU, Y [1 ]
机构
[1] YOKOHAMA CITY UNIV,SCH MED,DEPT PHARMACOL,YOKOHAMA 236,JAPAN
关键词
D O I
10.1254/jjp.48.153
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:153 / 156
页数:4
相关论文
共 14 条
[1]   ARTERIAL-WALLS GENERATE FROM PROSTAGLANDIN ENDOPEROXIDES A SUBSTANCE (PROSTAGLANDIN-X) WHICH RELAXES STRIPS OF MESENTERIC AND CELIAC ARTERIES AND INHIBITS PLATELET-AGGREGATION [J].
BUNTING, S ;
GRYGLEWSKI, R ;
MONCADA, S ;
VANE, JR .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (06) :897-913
[2]   PROSTACYCLIN IS MAJOR PROSTAGLANDIN RELEASED FROM ISOLATED PERFUSED RABBIT AND RAT-HEART [J].
DEDECKERE, EAM ;
NUGTEREN, DH ;
HOOR, FT .
NATURE, 1977, 268 (5616) :160-163
[3]  
EAKINS KE, 1973, ADV BIOSCI, V9, P135
[4]   EFFECTS OF INDOMETHACIN AND PROSTAGLANDINS-I2 AND PROSTAGLANDINS-E2 ON THE TONE OF HUMAN ISOLATED MESENTERIC-ARTERIES [J].
HADHAZY, P ;
NAGY, L ;
JUHASZ, F ;
MALOMVOLGYI, B ;
MAGYAR, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (04) :477-484
[5]   ACTIONS OF PROSTACYCLIN (PGI2) ON ADRENERGIC NEUROEFFECTOR TRANSMISSION IN THE RABBIT KIDNEY [J].
HEDQVIST, P .
PROSTAGLANDINS, 1979, 17 (02) :249-258
[6]   EFFECT OF PROSTACYCLIN ON MYOGENIC ACTIVITY AND ADRENERGIC NEUROEFFECTOR INTERACTION IN CANINE ISOLATED VEINS [J].
HERMAN, AG ;
VERBEUREN, TJ ;
MONCADA, S ;
VANHOUTTE, PM .
PROSTAGLANDINS, 1978, 16 (06) :911-921
[7]   CHEMICAL-STRUCTURE OF PROSTAGLANDIN-X (PROSTACYCLIN) [J].
JOHNSON, RA ;
MORTON, DR ;
KINNER, JH ;
GORMAN, RR ;
MCGUIRE, JC ;
SUN, FF ;
WHITTAKER, N ;
BUNTING, S ;
SALMON, J ;
MONCADA, S ;
VANE, JR .
PROSTAGLANDINS, 1976, 12 (06) :915-928
[8]  
MISU Y, 1981, J PHARMACOL EXP THER, V218, P242
[9]  
MONCADA S, 1977, LANCET, V1, P18
[10]   PREJUNCTIONAL AND POSTJUNCTIONAL ACTIONS OF PROSTAGLANDIN-F2-ALPHA AND PROSTAGLANDIN-I-2 AND CARBOCYCLIC THROMBOXANE-A2 IN ISOLATED DOG MESENTERIC-ARTERIES [J].
NAKAJIMA, M ;
TODA, N .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 120 (03) :309-318